Muscular Dystrophy
Muscular Dystrophy Canada is a national charitable organization founded in 1954 that supports over 27,000 Canadians affected by neuromuscular disorders through equipment funding, research grants, peer support, and advocacy, funded by donations, fire department partnerships, and corporate sponsorships.
- Company typePrivate
- Founded1954
- HeadquartersToronto, Canada
- Headcount51–100
- GTM typeB2C
- OfferingServices
What Muscular Dystrophy does
Muscular Dystrophy Canada (Dystrophie musculaire Canada) is a national Canadian charitable organization founded in 1954 by Dr. David Green and Arthur Minden, headquartered in Toronto, Ontario. The organization supports over 27,000 Canadians affected by neuromuscular disorders (NMDs) including muscular dystrophy, spinal muscular atrophy, myotonic dystrophy, and facioscapulohumeral muscular dystrophy, along with their families, caregivers, and the healthcare providers who serve them. Its core offerings include an Equipment Program providing financial assistance for mobility and accessibility devices, Research Grants funding clinical and translational neuromuscular research (investing nearly $1M CAD annually), Client Registration for service access, Peer Support programs, System Navigation assistance, a Research Hotline, and the Walk & Roll signature fundraising event.
Revenue is generated entirely through philanthropic channels: individual donations, corporate sponsorships (including pharmaceutical partners such as Janssen, EMD Serono, Vertex, Alexion, Biogen, and argenx), and a long-standing partnership with over 600 fire departments across Canada running Fill the Boot and similar fundraising campaigns. Walk & Roll events target $1.2M CAD annually. The organization also operates through co-founded research networks including the Neuromuscular Disease Network for Canada (NMD4C) with CIHR funding, and partners with the Canadian Neuromuscular Disease Registry (CNDR) and AccessNow. DMC is PIPEDA and PIPA compliant, holds the Imagine Canada Standards Program Trustmark, and operates bilingually in English and French. There is no technology product platform; the organization relies on donor databases, program management systems, and web-based service delivery rather than proprietary software.
Muscular Dystrophy firmographics
Firmographics- Name
- Muscular Dystrophy
- Legal name
- Muscular Dystrophy Canada
- Website
- https://muscle.ca
- Company type
- Private
- Founded year
- 1954
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Muscular Dystrophy Canada is a national charitable organization founded in 1954 that supports over 27,000 Canadians affected by neuromuscular disorders through equipment funding, research grants, peer support, and advocacy, funded by donations, fire department partnerships, and corporate sponsorships.
- Ownership category
- akta.pro rank
Muscular Dystrophy industry classification
Industry- Product category
- Neuromuscular Disorder Support Services
- NAICS
- Voluntary Health Organizations (813212), Grantmaking and Giving Services (8132), Grantmaking Foundations (813211)
- SIC
- Services-Social Services (8300), Services-Health Services (8000)
- akta.pro primary industry
- Disability Services & Independent Living Support (BPAGACAG)
- akta.pro secondary industry
- Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)
Keywords
Where Muscular Dystrophy is headquartered
LocationHeadquarters
- HQ city
- Toronto
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
Muscular Dystrophy business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Others
Revenue model
- Donations and Philanthropy: Primary revenue stream from individual donations, corporate sponsorships, and philanthropic contributions from the Canadian public. The organization relies on charitable donations to fund research grants, equipment programs, and support services.
- Fire Fighter Partnerships: Long-standing partnership with Canadian fire departments who fundraise through initiatives like Fill the Boot campaigns, providing significant ongoing support for the organization's mission.
- Event-Based Fundraising: Revenue generated through signature events including Walk & Roll, community-organized fundraisers, and annual campaigns. The Walk & Roll event targets $1.2 million annually.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Muscular Dystrophy product offering
Product offeringCore offering
Muscular Dystrophy Canada is a national charitable organization that delivers free support services, equipment funding, peer connections, and system navigation to Canadians affected by neuromuscular disorders. It funds neuromuscular research through grants and partnership programs (notably NMD4C), drives advocacy for newborn screening and treatment access, and runs the Walk & Roll signature fundraising event across multiple Canadian cities, all sustained through donations, sponsorships, grants, and over 600 fire department fundraising partners.
Product overview
Muscular Dystrophy Canada is a national charitable organization offering a unified portfolio of support services for Canadians affected by neuromuscular disorders. The core offerings include the Walk & Roll signature fundraising event, an Equipment Program providing mobility and accessibility funding, and Research Grants supporting neuromuscular research through partnerships with institutions like the Neuromuscular Disease Network for Canada. Complementary support services include a Research Hotline for treatment information, the Community Connection Fund for local events, Client Registration for full service access, Peer Support for community connection, and System Navigation for healthcare guidance. The organization also operates a Fire Fighters Partnership Program with over 600 fire departments nationwide.
Differentiator
Problem solved
Functional benefit
Products and services
- Walk & Roll for Muscular Dystrophy Canada Fully accessible signature fundraising event held in multiple Canadian cities each year, bringing together the neuromuscular community, families, fire departments and corporate national sponsors (Janssen, EMD Serono, Vertex, Alexion, Biogen, argenx) to raise funds for research, equipment, and support services, with a $1.2 million annual fundraising target. Individuals and teams can register via the Akari online platform.
- Equipment Program Funding program providing financial assistance to registered clients for the purchase of mobility and accessibility equipment (e.g., wheelchairs, accessible vans) needed to manage a neuromuscular disorder, available nationwide through the organization.
- Research Grants and Partnerships Funding program that invests approximately $1 million per year into neuromuscular research, including postdoctoral fellowships, clinical research projects, and co-funded partnerships such as the Neuromuscular Disease Network for Canada (NMD4C) with matching contributions to a CIHR IMHA 5-year grant.
- Research Hotline Service that helps individuals and families decode details about new discoveries, clinical trials, and emerging treatments, and provides current research information to the Canadian neuromuscular community at no charge.
- Community Connection Fund Small-grants program offering up to $500 per application for individuals, families, and community partners to create inclusive, community-led events that bring people affected by neuromuscular disorders together.
- Peer Support and Community Connection Program that connects individuals and families affected by neuromuscular disorders with peers and mentors across Canada for mutual support, shared experience, and reduced isolation through diagnosis and ongoing care.
- System Navigation One-on-one guidance service that helps clients understand and navigate Canadian healthcare systems, identify treatment options, and access appropriate regional resources after diagnosis.
- Walk & Roll Online Registration and Peer-to-Peer Fundraising Platform Self-serve online platform (Akari) that lets individuals register for Walk & Roll, create personal fundraising pages, and accept donations to support the organization's mission.
Quantifiable outcome
- Canada-wide newborn screening for spinal muscular atrophy implemented through advocacy efforts
- +3 more outcomes
Companies that use Muscular Dystrophy
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles2 records
Muscular Dystrophy technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Muscular Dystrophy partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and minor.
- Neuromuscular Disease Network for Canada (NMD4C)coreCo-founded partnership bringing together clinicians, scientists, and patient representatives to improve neuromuscular care, research, and collaboration. DMC provides matching funding ($40,000 annually) alongside a 5-year CIHR grant of $200,000 annually. Network has grown to over 500 members across Canada working on research infrastructure, clinical training, and treatment access.
- AccessNowminorAccessibility partnership to make travel more accessible for Canadians with neuromuscular disorders. AccessNow provides accessibility information to help DMC community members navigate travel with mobility equipment.
- Canadian Neuromuscular Disease Registry (CNDR)corePartnership to create a national patient registry and database for facioscapulohumeral muscular dystrophy (FSHD) to accelerate clinical trial access and treatment approvals in Canada. CNDR provides the registry infrastructure for collecting patient data to support regulatory approvals.
- Fire Fighters of CanadacoreOver 600 fire departments and associations across Canada support the NMD community through long-standing fundraising partnerships. Fire fighters have been allies since the organization's founding in 1954, contributing to research projects and ongoing community support through initiatives like Fill the Boot campaigns.
- Janssen (Pharmaceutical Companies)minorNational sponsor of Walk & Roll event, contributing to fundraising efforts for muscular dystrophy research and support services.
- EMD SeronominorNational sponsor of Walk & Roll event supporting the neuromuscular community through corporate sponsorship.
- Vertex PharmaceuticalsminorNational sponsor of Walk & Roll event contributing to fundraising for neuromuscular research and programs.
- Alexion PharmaceuticalsminorNational sponsor of Walk & Roll event supporting DMC programs and research funding.
- BiogenminorNational sponsor of Walk & Roll event supporting the neuromuscular community through corporate partnership.
- argenxminorNational sponsor of Walk & Roll event contributing to DMC's mission and community support.
- PTC TherapeuticsminorCorporate sponsor for limb girdle muscular dystrophy educational content, supporting awareness and information resources for the NMD community.
Scale indicators5 records
Recent moves7 records
Expansion highlights6 records
Muscular Dystrophy competitors and assessment
Company assessmentOthers
- Imagine Canada: National umbrella body that accredits Canadian charities (DMC holds its Trustmark) and sets sector governance standards; adjacent enabling organization in the Canadian charitable sector ecosystem.
Direct peers
- Muscular Dystrophy Association (MDA): The US counterpart to Muscular Dystrophy Canada with near-identical mission (NMD research, equipment, advocacy) and long-standing firefighter (Fill the Boot) fundraising model; the closest functional peer globally.
- ALS Society of Canada: Canadian voluntary health organization supporting Canadians affected by ALS, an adult-onset neuromuscular disorder, with similar equipment funding, peer support, research grants, and advocacy structure.
- March of Dimes Canada: Canadian nonprofit providing disability services, equipment funding, and accessibility programs across neuromuscular and mobility-related conditions; directly overlaps DMC's Equipment Program and accessibility advocacy.
- Multiple Sclerosis Society of Canada: Large Canadian nonprofit supporting people with MS (a neuromuscular/neurological disease) through research funding, service navigation, and advocacy; similar national structure, bilingual operations, and donor-funded revenue model.
- Cystic Fibrosis Canada: Canadian voluntary health charity funding CF research, clinical care, and patient support with comparable national fundraising apparatus and disease-specific research grant model.
Broad incumbents
- Canadian Cancer Society: Largest Canadian voluntary health organization, operating a research-funding, advocacy, and patient-support platform far broader than DMC, but sharing the Canadian national-charity operating model, donor base, and advocacy pathways.
- Heart & Stroke Foundation of Canada: Major Canadian voluntary health charity with similar national reach, signature events, corporate partnerships, and combined research-funding and patient-services model; competes for the same donor wallet.
- United Way Canada: Largest federated Canadian fundraising charity with overlapping corporate-partner and workplace-giving channels; competes for the same donor funding pool and corporate sponsorship dollars.
Emerging players
- Spinal Muscular Atrophy Canada: Note: SMA-focused charity (note: the Australian SMA charity is smaaustralia.org.au; the dedicated Canadian body is Cure SMA Canada). Smaller scale disease-specific NMD nonprofit; competes within the SMA subset of DMC's served base and on newborn-screening advocacy.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Muscular Dystrophy social profiles
Digital presenceMuscular Dystrophy compliance and trust
Trust signalCompliance3 records
Muscular Dystrophy financial estimates
Financial estimateRevenue estimate
Valuation estimate
Muscular Dystrophy leadership team
Management profileNumber of profiles
Profiles7 records
Muscular Dystrophy funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Muscular Dystrophy M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Muscular Dystrophy
What does Muscular Dystrophy do?
Muscular Dystrophy Canada is a national charitable organization that delivers free support services, equipment funding, peer connections, and system navigation to Canadians affected by neuromuscular disorders. It funds neuromuscular research through grants and partnership programs (notably NMD4C), drives advocacy for newborn screening and treatment access, and runs the Walk & Roll signature fundraising event across multiple Canadian cities, all sustained through donations, sponsorships, grants, and over 600 fire department fundraising partners.
Is Muscular Dystrophy a public or private company?
Muscular Dystrophy is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Muscular Dystrophy founded?
Muscular Dystrophy was founded in 1954. It employs 51 to 100 people.
Where is Muscular Dystrophy based?
Muscular Dystrophy is headquartered in Toronto, Canada, in the North America region.
How does Muscular Dystrophy make money?
Three revenue lines are on record. Donations and Philanthropy is the primary driver. The others are fire Fighter Partnerships and event-Based Fundraising.
Who are Muscular Dystrophy's main competitors?
Imagine Canada is listed as an others. Direct peers are Muscular Dystrophy Association (MDA), ALS Society of Canada, March of Dimes Canada, Multiple Sclerosis Society of Canada and Cystic Fibrosis Canada. Broad incumbents are Canadian Cancer Society, Heart & Stroke Foundation of Canada and United Way Canada. Spinal Muscular Atrophy Canada is listed as an emerging player.
Does Muscular Dystrophy have an API?
No public API is recorded for Muscular Dystrophy.
What industry is Muscular Dystrophy in?
Muscular Dystrophy's product category is Neuromuscular Disorder Support Services. Its primary akta.pro industry code is BPAGACAG, Disability Services & Independent Living Support, with a secondary code of BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS). Its NAICS code is 813212 and its SIC code is 8300.